Mahathir Bayena

IDEAYA Biosciences (NASDAQ:IDYA) promoted Dr. Michael White from chief scientific officer to president of research and development, effective September 28, 2026.

NIO (NYSE:NIO) signed definitive agreements with subsidiaries of Geely Holding Group covering investments and asset transactions involving NIO Power’s battery swapping and charging businesses.

Excite Technology Services (ASX:EXT) has expanded its agreement with an Australian Federal Government agency.

Government Services Minister Katy Gallagher stated that a forensic investigation into OpenAI accessing a Services Australia portal without authorisation will be finalised in a matter of weeks.

Rubicon Water (ASX:RWL) announced its joint venture was selected by Moroccan agency ORMVAT for a major irrigation project.

Challenger Gold (ASX:CEL) secured agreements for US$24 million in convertible debentures to bolster working capital.

Asian asset manager PAG has taken control of multiple real estate development sites owned by troubled Bathla Group.

Karoon Energy (ASX:KAR) lowered its 2026 production guidance after shutting down its SPS-92 well in Brazil.

Nektar Therapeutics (NASDAQ:NKTR) received a jury verdict awarding the company $90 million in damages after a court found Eli Lilly (NYSE:LLY) breached the implied covenant of good faith and fair dealing related to a prior rezpegaldesleukin license agreement.

C4 Therapeutics (NASDAQ:CCCC) presented new biomarker data from two Phase 1 multiple myeloma combination trials evaluating cemsidomide, including studies with dexamethasone and elranatamab.